{"id":"W2887847211","doi":"10.1080/23723556.2018.1481814","title":"CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead","year":2018,"lang":"en","type":"article","venue":"Molecular & Cellular Oncology","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Congressionally Directed Medical Research Programs; Canadian Cancer Society Research Institute; Terry Fox Research Institute; Government of Canada; Israel Cancer Research Fund","keywords":"Cdc25; PTEN; Triple-negative breast cancer; Breast cancer; Cancer research; Phosphatase; PIN1; Cancer; Medicine; Oncology; Internal medicine; PI3K/AKT/mTOR pathway; Biology; Enzyme; Phosphorylation; Signal transduction; Cell biology; Biochemistry; Cell cycle","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004426844,0.000357135,0.0003844032,0.00005145508,0.0002839708,0.00003104863,0.0006428995,0.0003595886,0.0001368326],"category_scores_gemma":[0.0001153132,0.000280931,0.0002338398,0.0001334847,0.0006052282,0.000006971007,0.0002435186,0.0001939383,0.00005221744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008394386,"about_ca_system_score_gemma":0.0003641623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002482789,"about_ca_topic_score_gemma":0.0003347776,"domain_scores_codex":[0.9977971,0.0003881147,0.000328107,0.0006821788,0.0001953577,0.0006091832],"domain_scores_gemma":[0.998502,0.00007835039,0.0002176796,0.0007956525,0.0002785921,0.0001277634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001221041,0.000273564,0.00007899173,0.00004328381,0.0004722271,0.00004237243,0.0002663548,0.00002019319,0.9395778,0.01228743,0.003515292,0.04220143],"study_design_scores_gemma":[0.001410847,0.001987637,0.0002021922,0.00001520746,0.00009622867,0.00006853275,0.000110255,0.00007949581,0.7998503,0.005236634,0.1906487,0.0002939613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4714214,0.3922519,0.05915153,0.05328956,0.003408731,0.009190653,0.001580342,0.0002289826,0.009476854],"genre_scores_gemma":[0.9917262,0.0008236712,0.001519553,0.003585746,0.0007371958,0.0009488234,0.000177624,0.0000869028,0.0003942465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5203048,"threshold_uncertainty_score":0.9999643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01939120539736509,"score_gpt":0.3099409578009168,"score_spread":0.2905497524035517,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}